| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.0087 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.0077 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.0062 | 1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |